Bloomberg News

Pfizer Beats Estimates, Revises Forecast

May 01, 2012

Bloomberg's Dominic Chu reports that Pfizer Inc., the world’s largest drugmaker, reported profit that beat analyst estimates as growth in China helped overcome revenue lost to generic competition for the cholesterol pill Lipitor. The company trimmed its 2012 forecast after the sale of a unit. He speaks on Bloomberg Television's "Inside Track." (Source: Bloomberg)

Running Time: 02:12


The Good Business Issue
LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus